S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Advaxis Receives Notice of Allowance From U.S. Patent Office for Two Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy ADXS-cHER2|
|Advaxis Evaluates Higher Dose and Repeat Cycles of ADXS-HPV in Phase 1/2 Cervical Cancer Trial|
|Advaxis to be Added to Russell Microcap Index|
|Advaxis and MedImmune Partner on Immuno-Oncology Combination Clinical Trial|
|Advaxis Announces Filing for USDA Product License|
|Advaxis and the University of Pennsylvania Restructure Their Exclusive License Agreement|
|Advaxis Receives Notice of Allowance for Cancer Immunotherapies Patent in Japan|
|Advaxis's Cancer Immunotherapy Featured on CBS News|
|The Adams Express Fund Declares Dividend And Reports Performance For The First Half Of 2014|
|Advaxis and Merck Form Collaboration to Evaluate Investigational Combination of Two Novel Immunotherapy Candidates for Advanced Prostate Cancer|
Click above to view more mutual fund data and stats for adxs - Advaxis Inc.